TCC
Well-known
FDA Commissioner Marty Makary Announces Major New Policy to Limit Conflicts of Interest
FDA Commissioner Marty Makary joins Megyn to discuss policy changes he is making at the agency to restore public trust.
The Make America Healthy Again (MAHA) movement proved to be more than just a campaign talking point for Donald Trump. Robert F. Kennedy Jr. is now heading up the Department of Health and Human Services (HHS), and Marty Makary, MD, was tapped to lead the Food and Drug Administration (FDA).
Dr. Makary breezed through the Senate confirmation process (even getting the support of a few Democrats along the way), and has now been at the FDA for 17 days. His time thus far has been spent listening and learning to get a better sense of the state of the agency and what needs to be done to restore the public trust that eroded during the COVID pandemic.
On Thursday’s show, Megyn traveled to FDA headquarters to sit down with Dr. Makary for his first interview as commissioner and learn more about steps he is already taking to limit conflicts of interest with Big Pharma.